National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
Topics
- Adverse Drug Events (ADE) (1)
- Alcohol Use (1)
- Children/Adolescents (2)
- Chronic Conditions (5)
- Clinical Decision Support (CDS) (1)
- Clinician-Patient Communication (3)
- Communication (1)
- Comparative Effectiveness (2)
- Depression (1)
- Diabetes (1)
- Diagnostic Safety and Quality (1)
- Disparities (2)
- Education: Academic (1)
- Education: Continuing Medical Education (1)
- Education: Patient and Caregiver (2)
- Elderly (1)
- Electronic Health Records (EHRs) (1)
- Emergency Medical Services (EMS) (1)
- Evidence-Based Practice (2)
- Guidelines (1)
- Healthcare Cost and Utilization Project (HCUP) (2)
- Healthcare Costs (5)
- Healthcare Delivery (2)
- Health Information Exchange (HIE) (1)
- Health Information Technology (HIT) (3)
- Health Insurance (3)
- Health Status (1)
- Heart Disease and Health (1)
- Hepatitis (2)
- Hospitalization (2)
- Hospital Readmissions (1)
- (-) Human Immunodeficiency Virus (HIV) (51)
- Infectious Diseases (2)
- Injuries and Wounds (1)
- Lifestyle Changes (2)
- Low-Income (1)
- Medicaid (5)
- Medicare (2)
- Medication (12)
- Men's Health (1)
- Mortality (2)
- Nutrition (1)
- Obesity: Weight Management (1)
- Outcomes (1)
- Palliative Care (1)
- Patient-Centered Healthcare (1)
- Patient-Centered Outcomes Research (1)
- Patient Adherence/Compliance (6)
- Patient and Family Engagement (1)
- Patient Experience (1)
- Patient Self-Management (2)
- Policy (2)
- Pregnancy (1)
- Prevention (8)
- Primary Care (1)
- Provider (1)
- Public Health (2)
- Quality Measures (1)
- Quality of Care (1)
- Quality of Life (2)
- Racial and Ethnic Minorities (8)
- Respiratory Conditions (2)
- Risk (6)
- Screening (3)
- Sexual Health (1)
- Simulation (1)
- Sleep Problems (1)
- Social Determinants of Health (2)
- Social Stigma (3)
- Substance Abuse (3)
- Telehealth (2)
- Tobacco Use (2)
- U.S. Preventive Services Task Force (USPSTF) (2)
- Urban Health (3)
- Vulnerable Populations (3)
- Women (1)
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 25 of 51 Research Studies DisplayedWurcel AG, Guardado R, Grussing ED
Racial differences in testing for infectious diseases: an analysis of jail intake data.
This analysis examines HIV and hepatitis C virus (HCV) testing in Middlesex House of Corrections (MHOC) in Massachusetts. Only 38% of incarcerated individuals who requested testing received it. Black non-Hispanic and Hispanic individuals were more likely to request and complete testing compared to white individuals. These disparities may reflect broader issues of access to care. The study highlights the need for improved testing completion rates and interdisciplinary collaboration in jails.
AHRQ-funded; HS026008.
Citation: Wurcel AG, Guardado R, Grussing ED .
Racial differences in testing for infectious diseases: an analysis of jail intake data.
PLoS One 2023 Dec 20; 18(12):e0288254. doi: 10.1371/journal.pone.0288254.
Keywords: Hepatitis, Human Immunodeficiency Virus (HIV), Racial and Ethnic Minorities, Vulnerable Populations
Wiehe SE, Nelson TL, Aalsma MC
HIV care continuum among people living with HIV and history of arrest and mental health diagnosis.
The purpose of this retrospective cohort study was to explore relationships between the overlap of justice involvement and psychiatric comorbidities with HIV outcomes among people living with HIV (PLWH). The researchers included 5,730 PLWH 13 years of age and older living in Marion County Indiana in 2018. The study found that linkage to care (LTC) decreased among those with an arrest vs those without an arrest. Mental health diagnoses had no significant impact on LTC. The researchers controlled for demographics and substance use disorder and the resulting analyses indicated a protective effect of arrest history on the likelihood of retention in care (RIC) and undetectable viral load (UVL). Having a diagnosis of a mental health issue also increased the likelihood of RIC and UVL. The study results were mediated by outpatient care use, but an arrest or the diagnosis of a mental health issue increased the likelihood of RIC among PLWH and a history of low use of outpatient services.
AHRQ-funded; HS023318; HS024296.
Citation: Wiehe SE, Nelson TL, Aalsma MC .
HIV care continuum among people living with HIV and history of arrest and mental health diagnosis.
J Acquir Immune Defic Syndr 2023 Dec 15; 94(5):403-11. doi: 10.1097/qai.0000000000003296..
Keywords: Human Immunodeficiency Virus (HIV)
Tracer H, Lorei NC
AHRQ Author: Tracer H
Preexposure prophylaxis to prevent acquisition of HIV.
This case study described a 28-year-old woman presented to a community health clinic for sexually transmitted infection (STI) testing. Case study questions related to the USPSTF recommendation on Preexposure Prophylaxis (PrEP) to prevent acquisition of HIV, guidelines for candidacy for PrEP, guidelines for the use of PrEP for the primary prevention of HIV in adults.
AHRQ-authored.
Citation: Tracer H, Lorei NC .
Preexposure prophylaxis to prevent acquisition of HIV.
Am Fam Physician 2023 Dec; 108(6):617-18..
Keywords: U.S. Preventive Services Task Force (USPSTF), Human Immunodeficiency Virus (HIV), Prevention, Evidence-Based Practice
Ruderman SA, Odden MC, Webel AR
Tobacco smoking and pack-years are associated with frailty among people with HIV.
This study examines the association of frailty with tobacco smoking and pack-years among people with HIV (PWH). The authors identified 8,608 PWH across 6 Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) sites who completed ≥2 patient-reported outcome assessments, including a frailty phenotype measuring unintentional weight loss, poor mobility, fatigue, and inactivity, scored 0-4. The authors measured smoking as baseline pack-years and time-updated never, former, or current use with cigarettes/day. They used Cox models to associate smoking with risk of incident frailty (score ≥3) and deterioration (frailty score increase by ≥2 points), adjusted for demographics, antiretroviral medication, and time-updated CD4 count. Mean follow-up period of PWH was 5.3 years, the mean age at baseline was 45 years, 15% were female, and 52% were non-White. At baseline, 60% reported current or former smoking and both were associated with higher incident frailty risk, as was higher pack-years. Current smoking (among younger PWH) and pack-years were associated with higher risk of deterioration, but not former smoking.
AHRQ-funded; HS026154.
Citation: Ruderman SA, Odden MC, Webel AR .
Tobacco smoking and pack-years are associated with frailty among people with HIV.
J Acquir Immune Defic Syndr 2023 Oct 1; 94(2):135-42. doi: 10.1097/qai.0000000000003242..
Keywords: Tobacco Use, Human Immunodeficiency Virus (HIV), Chronic Conditions, Health Status
Chou R, Spencer H, Bougatsos C
Preexposure prophylaxis for the prevention of HIV: updated evidence report and systematic review for the US Preventive Services Task Force.
This article updates research used in the 2019 US Preventive Services Task Force final recommendation on use of oral preexposure prophylaxis (PrEP) to prevent HIV in adults at increased risk. The summary includes newer PrEP regimens that were not available for the 2019 final recommendation. A literature review was conducted that included randomized clinical trials of PrEP vs placebo or no PrEP or newer vs older PrEP regimens and diagnostic accuracy studies of instruments for predicting incident HIV infection. Thirty-two studies were included in the review (20 randomized clinical trials [n = 36,543] and 12 studies of diagnostic accuracy [n = 5,544,500]). Eleven trials in the 2019 review found oral PrEP associated with decreased HIV infection risk vs placebo or no PrEP. One new trial (n = 5335) found oral tenofovir alafenamide/emtricitabine (TAF/FTC) to be noninferior to tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) in men who have sex with men. Two new trials found long-acting injectable cabotegravir associated with decreased risk of HIV infection vs oral TDF/FTC in cisgender men who have sex with men and transgender women [n = 4490] and RR, 0.11 in cisgender women [n = 3178]). Discrimination of instruments for predicting incident HIV infection was found to be moderate in men who have sex with men (5 studies; n = 25,488) and moderate to high in general populations of persons without HIV (2 studies; n = 5,477,291).
AHRQ-funded; 75Q80120D00006.
Citation: Chou R, Spencer H, Bougatsos C .
Preexposure prophylaxis for the prevention of HIV: updated evidence report and systematic review for the US Preventive Services Task Force.
JAMA 2023 Aug 22; 330(8):746-63. doi: 10.1001/jama.2023.9865..
Keywords: U.S. Preventive Services Task Force (USPSTF), Human Immunodeficiency Virus (HIV), Prevention, Medication, Evidence-Based Practice
Teixeira da Silva D, Makeneni S, Wall H
Measuring quality STI care among adolescent female primary care patients in Philadelphia.
The purpose of this study was to develop and apply a cross-setting, sexually transmitted infection (STI) Care Continuum to improve STI care quality, to assess adherence to guideline-recommended care, and to standardize progress measurement toward National Strategic goals. Review of the CDC STI treatment guidelines identified seven distinct steps of care for gonorrhea, chlamydia, and syphilis; researchers used Youth Risk Behavior Surveillance Survey data to estimate step 1, and electronic health record data for steps 2, 3, 4, 6 and 7. The researchers concluded that local application of an STI Care Continuum identified STI testing, retesting, and HIV testing as areas for improvement. Similar methods may be applied to target resources, standardize data collection and reporting, and improve STI care quality.
AHRQ-funded; HS026116.
Citation: Teixeira da Silva D, Makeneni S, Wall H .
Measuring quality STI care among adolescent female primary care patients in Philadelphia.
Sex Transm Infect 2023 Jun; 99(4):272-75. doi: 10.1136/sextrans-2022-055623..
Keywords: Children/Adolescents, Sexual Health, Infectious Diseases, Primary Care, Women, Human Immunodeficiency Virus (HIV), Quality Measures, Quality of Care
Ruderman SA, Nance RM, Drumright LN
Development of Frail RISC-HIV: a risk score for predicting frailty risk in the short-term for care of people with HIV.
The authors developed RISC-HIV, a frailty prediction risk score for HIV clinical decision-making. They predicted frailty risk among people with HIV (PWH) at seven US HIV clinics and followed for up to 2 years to identify short-term predictors of becoming frail. They concluded that RISC-HIV is a simple, easily implemented tool to assist in classifying PWH at risk for frailty in clinics.
AHRQ-funded; HS026154.
Citation: Ruderman SA, Nance RM, Drumright LN .
Development of Frail RISC-HIV: a risk score for predicting frailty risk in the short-term for care of people with HIV.
AIDS 2023 May 1; 37(6):967-75. doi: 10.1097/qad.0000000000003501..
Keywords: Human Immunodeficiency Virus (HIV), Risk
Schnall R, Sanabria G, Jia R, Sanabria G, Jia H
Efficacy of an mHealth self-management intervention for persons living with HIV: the WiseApp randomized clinical trial.
This study’s objective was to determine the efficacy of WiseApp, a user-centered design mHealth intervention to improve antiretroviral therapy (ART) adherence and viral suppression in persons living with HIV (PLWH). This randomized case-control trial had two study arms: a randomized controlled efficacy trial arm (n = 99) and an attention control intervention arm (n = 101) among PLWH living in New York City. The authors found a significant improvement in ART adherence in the intervention arm compared to the attention control arm from day 1 (69.7% vs 48.3%) to day 59 (51.2% vs 37.2%) of the study period. From day 60 to 120, the intervention had higher but not statistically significant adherence rates. Secondary analyses showed no difference in change from baseline to 3 or 6 months between the 2 study arms.
AHRQ-funded; HS025071.
Citation: Schnall R, Sanabria G, Jia R, Sanabria G, Jia H .
Efficacy of an mHealth self-management intervention for persons living with HIV: the WiseApp randomized clinical trial.
J Am Med Inform Assoc 2023 Feb 16; 30(3):418-26. doi: 10.1093/jamia/ocac233..
Keywords: Telehealth, Patient Self-Management, Human Immunodeficiency Virus (HIV), Chronic Conditions, Health Information Technology (HIT)
Sun CJ, Shato T, Steinbaugh A
Virtual voices: examining social support exchanged through participant-generated and unmoderated content in a mobile intervention to improve HIV antiretroviral therapy adherence among GBMSM.
The goal of this study was to investigate how social support was provided and sought by gay, bisexual, and other men who have sex with men (GBMSM) within a technology-based antiretroviral therapy (ART) adherence intervention. Participants used the messaging feature in to discuss and exchange support around HIV treatment and care. The most salient HIV treatment and care issues were lab results, upcoming tests, ART adherence and side effects, regimen changes, and relationships with healthcare providers. The authors concluded that this analysis provided an opportunity to understand how participants informally interact with one another, how they seek and provide social support online, and their relevant personal issues.
AHRQ-funded; HS022981.
Citation: Sun CJ, Shato T, Steinbaugh A .
Virtual voices: examining social support exchanged through participant-generated and unmoderated content in a mobile intervention to improve HIV antiretroviral therapy adherence among GBMSM.
AIDS Care 2023 Jan;35(1):7-15. doi: 10.1080/09540121.2022.2038364.
Keywords: Patient Adherence/Compliance, Human Immunodeficiency Virus (HIV), Telehealth, Health Information Technology (HIT), Medication, Vulnerable Populations
Nikolopoulos GK, Pavlitina E, Muth SQ
A network intervention that locates and intervenes with recently HIV-infected persons: the Transmission Reduction Intervention Project (TRIP).
The Transmission Reduction Intervention Project (TRIP) evaluated a network intervention to detect individuals infected with HIV within the past 6 months. Results indicated that strategic network tracing that starts with recently infected persons could support public health efforts to find and treat people early in their HIV infection.
AHRQ-funded; HS000084.
Citation: Nikolopoulos GK, Pavlitina E, Muth SQ .
A network intervention that locates and intervenes with recently HIV-infected persons: the Transmission Reduction Intervention Project (TRIP).
Sci Rep 2016 Dec 5;6:38100. doi: 10.1038/srep38100.
.
.
Keywords: Human Immunodeficiency Virus (HIV), Prevention, Public Health
Salinas JL, Rentsch C, Marconi VC
Baseline, time-updated, and cumulative HIV care metrics for predicting acute myocardial infarction and all-cause mortality.
The researchers studied prediction rates of myocardial infarction in those with HIV. They found that the Veterans Aging Cohort Study (VACS) Index provided better acute myocardial infarction and mortality prediction than CD4 count and HIV-1 RNA, concluding that current health determines risk more accurately than prior history.
AHRQ-funded; HS018372.
Citation: Salinas JL, Rentsch C, Marconi VC .
Baseline, time-updated, and cumulative HIV care metrics for predicting acute myocardial infarction and all-cause mortality.
Clin Infect Dis 2016 Dec 1;63(11):1423-30. doi: 10.1093/cid/ciw564.
.
.
Keywords: Human Immunodeficiency Virus (HIV), Mortality, Heart Disease and Health, Risk
Merlin JS, Bulls HW, Vucovich LA
Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review.
The authors conducted a systematic review to identify clinical trials and observational studies examining the impact of pharmacologic or non-pharmacologic interventions on pain and/or functional outcomes among HIV-infected individuals with chronic pain in high-development countries. They found that the only included controlled studies with positive results were of capsaicin and cannabis. Among the seven studies of pharmacologic interventions, the authors determined that five had substantial pharmaceutical industry sponsorship. Their findings highlight several important gaps in the HIV/chronic pain literature requiring further research.
AHRQ-funded; HS019465.
Citation: Merlin JS, Bulls HW, Vucovich LA .
Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review.
AIDS Care 2016 Dec;28(12):1506-15. doi: 10.1080/09540121.2016.1191612.
.
.
Keywords: Chronic Conditions, Comparative Effectiveness, Human Immunodeficiency Virus (HIV), Medication, Patient-Centered Outcomes Research
Gaines TL, Caldwell JT, Ford CL
Relationship between a Centers for Disease Control and Prevention expanded HIV testing initiative and past-year testing by race/ethnicity: a multilevel analysis of the Behavioral Risk Factor Surveillance System.
The Centers for Disease Control and Prevention's (CDC) expanded testing initiative (ETI) aims to bolster HIV testing among populations disproportionately affected by the HIV epidemic by providing additional funding to health departments serving these communities. Controlling for individual- and state-level characteristics, ETI participation was independently and positively associated with past-year testing, but this association varied by race/ethnicity.
AHRQ-funded; HS022811.
Citation: Gaines TL, Caldwell JT, Ford CL .
Relationship between a Centers for Disease Control and Prevention expanded HIV testing initiative and past-year testing by race/ethnicity: a multilevel analysis of the Behavioral Risk Factor Surveillance System.
AIDS Care 2016;28(5):554-60. doi: 10.1080/09540121.2015.1131968.
.
.
Keywords: Human Immunodeficiency Virus (HIV), Screening, Prevention, Racial and Ethnic Minorities
Earnshaw VA, Rosenthal L, Lang SM
Stigma, activism, and well-being among people living with HIV.
The researchers examined associations between experiences of HIV stigma and HIV activism, and test whether HIV activists benefit from greater well-being than non-activists. Their results suggest that HIV activists reported greater social network integration, greater social well-being, greater engagement in active coping with discrimination, and greater meaning in life than non-activists.
AHRQ-funded; HS022986.
Citation: Earnshaw VA, Rosenthal L, Lang SM .
Stigma, activism, and well-being among people living with HIV.
AIDS Care 2016;28(6):717-21. doi: 10.1080/09540121.2015.1124978.
.
.
Keywords: Human Immunodeficiency Virus (HIV), Quality of Life, Depression, Social Determinants of Health, Social Stigma
Haines CF, Fleishman JA, Yehia BR
AHRQ Author: Fleishman JA
Closing the gap in antiretroviral initiation and viral suppression: time trends and racial disparities.
In the current antiretroviral (ART) era, the evolution of HIV guidelines and emergence of new ART agents might be expected to impact the times to ART initiation (AI) and HIV virologic suppression. The researchers sought to determine if times to AI and virologic suppression decreased and if disparities exist. Since 2007, times from enrollment to AI and virologic suppression have decreased significantly compared with 2003-2004.
AHRQ-authored.
Citation: Haines CF, Fleishman JA, Yehia BR .
Closing the gap in antiretroviral initiation and viral suppression: time trends and racial disparities.
J Acquir Immune Defic Syndr 2016 Nov 1;73(3):340-47. doi: 10.1097/qai.0000000000001114.
.
.
Keywords: Human Immunodeficiency Virus (HIV), Disparities, Racial and Ethnic Minorities
Morgan E, Khanna AS, Skaathun B
Marijuana use among young black men who have sex with men and the HIV care continuum: findings from the uConnect cohort.
The authors investigated how substances most commonly used by young black men who have sex with men (YBMSM), such as marijuana, are related to the HIV continuum. They found that YBMSM who used marijuana heavily were more likely to be HIV-positive unaware than those who never used marijuana..
AHRQ-funded; HS000084.
Citation: Morgan E, Khanna AS, Skaathun B .
Marijuana use among young black men who have sex with men and the HIV care continuum: findings from the uConnect cohort.
Subst Use Misuse 2016 Nov 9;51(13):1751-9. doi: 10.1080/10826084.2016.1197265.
.
.
Keywords: Human Immunodeficiency Virus (HIV), Racial and Ethnic Minorities, Racial and Ethnic Minorities, Substance Abuse
Ramos SR, Gordon P, Bakken S
Sociotechnical analysis of health information exchange consent processes in an HIV clinic.
The purpose of this study was to describe sociotechnical factors that influence health information exchange (HIE) consent for persons living with HIV (PLWH) at one clinic in New York City. The authors' approach revealed multiple interruptions in clinical workflow, staff and providers' time constraints, and lack of dedicated personnel focused on HIE consent as the major barriers to HIE consent, and they recommended having a dedicated person for facilitating HIE consent.
AHRQ-funded; HS023963.
Citation: Ramos SR, Gordon P, Bakken S .
Sociotechnical analysis of health information exchange consent processes in an HIV clinic.
J Assoc Nurses AIDS Care 2016 Nov - Dec;27(6):792-803. doi: 10.1016/j.jana.2016.08.001.
.
.
Keywords: Electronic Health Records (EHRs), Health Information Exchange (HIE), Health Information Technology (HIT), Human Immunodeficiency Virus (HIV)
Tiruneh YM, Wilson IB
What time is it? Adherence to antiretroviral therapy in Ethiopia.
This study assessed adherence to antiretroviral therapy (ART) among people living with HIV/AIDS in Ethiopia and explored the sociocultural context in which they relate to their regimen requirements. Its findings indicate that study participants are highly adherent to dose but less adherent to dose schedule. Strict dose time instructions were reported as stressful and unrealistic.
AHRQ-funded; HS000011.
Citation: Tiruneh YM, Wilson IB .
What time is it? Adherence to antiretroviral therapy in Ethiopia.
AIDS Behav 2016 Nov;20(11):2662-73. doi: 10.1007/s10461-016-1322-0.
.
.
Keywords: Patient Adherence/Compliance, Human Immunodeficiency Virus (HIV), Medication
Herrin M, Tate JP, Akgun KM
Weight gain and incident diabetes among HIV-infected veterans initiating antiretroviral therapy compared with uninfected individuals.
The authors used data from the Veterans Aging Cohort Study to determine whether weight gain after antiretroviral therapy has a similar association with incident type 2 diabetes mellitus as weight gained among HIV-uninfected individuals. They found that weight gained during the first year after antiretroviral therapy initiation is associated with greater risk of diabetes mellitus than that among uninfected individuals.
AHRQ-funded; HS018372.
Citation: Herrin M, Tate JP, Akgun KM .
Weight gain and incident diabetes among HIV-infected veterans initiating antiretroviral therapy compared with uninfected individuals.
J Acquir Immune Defic Syndr 2016 Oct 1;73(2):228-36. doi: 10.1097/qai.0000000000001071.
.
.
Keywords: Diabetes, Human Immunodeficiency Virus (HIV), Medication, Obesity: Weight Management
Eaton EF, Tamhane A, Saag M
Cost considerations in the current antiretroviral era.
The authors analyzed the relative cost-effectiveness of contemporary antiretroviral therapy in real-world clinical settings. They found that, among the participants studied, raltegravir and efavirenz-based regimens were the most cost-effective options for treatment-naive patients. They suggested that these findings are relevant given changes in recommended regimens for treatment-naive persons. The authors recommended that further data on the comparative effectiveness of efavirenz and rilpivirine are needed.
AHRQ-funded; HS013852.
Citation: Eaton EF, Tamhane A, Saag M .
Cost considerations in the current antiretroviral era.
AIDS 2016 Sep 10;30(14):2115-9. doi: 10.1097/qad.0000000000001120.
.
.
Keywords: Healthcare Costs, Human Immunodeficiency Virus (HIV), Medication
McManus KA, Rodney RC, Rhodes A
Affordable Care Act qualified health plan enrollment for AIDS Drug Assistance Program clients: Virginia's experience and best practices.
This article highlighted the benefits of the Affordable Care Act (ACA) for persons living with HIV and described the range of strategies employed by states to enroll patients in Qualified Health Plans (QHPs). It used the Virginia AIDS Drug Assistance Program ACA implementation to illustrate one program's shift to purchasing QHPs. The authors provided practical details of Virginia's implementation as well as insights and best practices at both the state and clinic level.
AHRQ-funded; HS024196.
Citation: McManus KA, Rodney RC, Rhodes A .
Affordable Care Act qualified health plan enrollment for AIDS Drug Assistance Program clients: Virginia's experience and best practices.
AIDS Res Hum Retroviruses 2016 Sep;32(9):885-91. doi: 10.1089/aid.2016.0033.
.
.
Keywords: Human Immunodeficiency Virus (HIV), Medication, Policy
Tetrault JM, Tate JP, Edelman EJ
Hepatic safety of buprenorphine in HIV-Infected and uninfected patients with opioid use disorder: the role of HCV-infection.
The purpose of this paper was to examine risk for buprenorphine (BUP)-associated hepatotoxicity among individuals with HIV and HCV. The authors found that liver enzymes and total bilirubin are rarely elevated in HIV-infected and uninfected patients receiving BUP, and that the risk of hepatotoxicity was greater in individuals infected with HIV, HCV, or HIV/HCV co-infection, who may benefit from increased monitoring.
AHRQ-funded; HS021112; HS018372.
Citation: Tetrault JM, Tate JP, Edelman EJ .
Hepatic safety of buprenorphine in HIV-Infected and uninfected patients with opioid use disorder: the role of HCV-infection.
J Subst Abuse Treat 2016 Sep;68:62-7. doi: 10.1016/j.jsat.2016.06.002.
.
.
Keywords: Adverse Drug Events (ADE), Hepatitis, Human Immunodeficiency Virus (HIV), Medication, Risk
Yin MT, Shiau S, Rimland D
Fracture prediction with modified-FRAX in older HIV-infected and uninfected men.
The authors investigated considering HIV as a cause of secondary osteoporosis when calculating FRAX, a clinical fracture risk calculator, in HIV-infected individuals. They found that modified-FRAX underestimated the fracture rates more in older HIV-infected than in otherwise similar uninfected men. and they recommend further studies to determine how to risk stratify for screening and treatment in older HIV-infected individuals.
AHRQ-funded; HS018372.
Citation: Yin MT, Shiau S, Rimland D .
Fracture prediction with modified-FRAX in older HIV-infected and uninfected men.
J Acquir Immune Defic Syndr 2016 Aug 15;72(5):513-20. doi: 10.1097/qai.0000000000000998.
.
.
Keywords: Clinical Decision Support (CDS), Elderly, Injuries and Wounds, Human Immunodeficiency Virus (HIV), Risk
McManus KA, Rhodes A, Bailey S
Affordable Care Act qualified health plan coverage: association with improved HIV viral suppression for AIDS drug assistance program clients in a Medicaid nonexpansion state.
The objective of this study was to characterize the demographic and healthcare delivery factors associated with Virginia AIDS Drug Assistance Programs (ADAPs) clients' qualified health plan (QHP) enrollment and to assess the relationship between qualified health coverage and human immunodeficiency virus (HIV) viral suppression. It concluded that QHP coverage was associated with viral suppression, an essential outcome for individuals and for public health.
AHRQ-funded; HS024196.
Citation: McManus KA, Rhodes A, Bailey S .
Affordable Care Act qualified health plan coverage: association with improved HIV viral suppression for AIDS drug assistance program clients in a Medicaid nonexpansion state.
Clin Infect Dis 2016 Aug;63(3):396-403. doi: 10.1093/cid/ciw277.
.
.
Keywords: Health Insurance, Human Immunodeficiency Virus (HIV), Medicaid, Medication, Outcomes
Fleishman JA, Monroe AK, Voss CC
AHRQ Author: Fleishman JA
Expenditures for persons living with HIV enrolled in Medicaid, 2006-2010.
The researchers used Medicaid claims data to comprehensively assess payments for care for persons living with HIV between 2006 and 2010. They found that estimated Medicaid payment amounts are higher than some prior estimates. More complete capture of expensive inpatient hospitalizations in Medicaid data may partially explain this finding.
AHRQ-authored.
Citation: Fleishman JA, Monroe AK, Voss CC .
Expenditures for persons living with HIV enrolled in Medicaid, 2006-2010.
J Acquir Immune Defic Syndr 2016 Aug 1;72(4):408-15. doi: 10.1097/qai.0000000000000985.
.
.
Keywords: Human Immunodeficiency Virus (HIV), Medicaid, Healthcare Costs